Journal article

Minimizing the risks associated with significant QTc prolongation in people with schizophrenia: A consensus statement by the Cardiac Safety in Schizophrenia Group

D Ames, J Camm, P Cook, P Falkai, C Gury, R Hurley, G Johnson, R Piepho, V Vieweg

Australasian Psychiatry | Published : 2002


Cardiac Safety in Schizophrenia Group Objectes: This study was designed to help identify and clarify issues associated with cardiac safety in schizophrenia, particularly QTc interval prolongation; to raise awareness among psychiatrists of the cardiac issues involved in prescribing for schizophrenia and help psychiatrists minimise the potential cardiac risks associated with treating schizophrenia. Methods: The currently available literature on cardiac dysfunction associated with antipsychotic treatments was reviewed by an independent panel of international psychiatric and cardiology experts. Following individual review, a joint meeting was held and a consensus statement produced. Results: ..

View full abstract

University of Melbourne Researchers

Citation metrics